Epidermal growth factor receptor (EGFR) is not related to the prognosis of cervical cancer
- 1 January 1998
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 123 (2), 135-139
- https://doi.org/10.1016/s0304-3835(97)00421-7
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapyBritish Journal of Cancer, 1995
- Effect of recombinant human interferon‐alpha/2b on epidermal‐growth‐factor‐, estrogen‐ and progesterone‐receptor expression in primary cervical cancerInternational Journal of Cancer, 1994
- Significance of epidermal growth factor receptor expression in primary human endometrial cancerInternational Journal of Cancer, 1994
- Prognostic value of epidermal growth factor receptor expression in cervical carcinoma.Journal of Clinical Pathology, 1993
- Effect of recombinant human interferon-alpha2b on receptors for steroid hormones and epidermal growth factor in patients with endometrial cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Expression of ras oncogene product and EGF receptor in cervical squamous cell carcinomas and its relationship to lymph node involvementGynecologic Oncology, 1991
- Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factors for response and survivalCancer, 1991
- Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervixGynecologic Oncology, 1989
- The occurrence of epidermal growth factor receptors and the characterization of EGF-like factors in human ovarian, endometrial, cervical and breast cancerZeitschrift für Krebsforschung und Klinische Onkologie, 1989
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958